Filing Flows › Novartis AG (NVS) › Q1 2026
Novartis AG (NVS) Q1 2026 earnings results (first quarter 2026)
6-K filed Apr 28, 2026
Novartis AG (NVS) reported revenue of $13.1B for the first quarter 2026 (Q1 2026), -0.9% from a year earlier. Operating margin was 32.3%, net earnings $3.2B (24.1% of revenue).
Novartis AG, Q1 2026: revenue $13.1B (-0.9% year over year), operating margin 32.3%, net earnings $3.2B. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.1B | — | -0.9% |
| Operating profit | $4.2B | — | -9% |
| Net earnings | $3.2B | — | -13% |
What changed
Revenue was $13.1B in Q1 2026, down 1% year over year.
Operating profit was $4.2B, a 32.3% margin (down 2.9 points year over year). Total costs grew 4% against a revenue fall of 1%. Net earnings were $3.2B, down 13% year over year. The effective tax rate was 0.0%.
Questions
What was Novartis AG's revenue in the first quarter 2026?
Novartis AG (NVS) reported revenue of $13.1B for the first quarter 2026 (Q1 2026), -0.9% from a year earlier.
Was Novartis AG profitable in the first quarter 2026?
Operating profit was $4.2B (32.3% of revenue) and net earnings $3.2B.
Source: Novartis AG 6-K on SEC EDGAR.